Pharmacy, Pharma & PBMs

How to measure the long-term value of GLP-1s within employer healthcare costs

Employers are facing a difficult balancing act. GLP-1 medications offer significant opportunities to improve employee health, particularly for individuals living with obesity, diabetes and related chronic conditions. Yet their growing utilization is adding…

NASHP Overview: State Strategies for Medicaid Pharmacy Benefit Management

Explore how state Medicaid agencies are changing pharmacy benefit management strategies to improve transparency, reduce costs and oversee PBMs.

CMS Issues Final Rule on the Medicare Drug Price Negotiation Program and Medicare Prescription Drug Benefit Program

CMS Issues Final Rule on the Medicare Drug Price Negotiation Program and Medicare Prescription Drug Benefit Program spassin@amcp.org Fri, 11/06/2026 - 14:43 On November 5, 2026, the Centers for Medicare and Medicaid Services issued a final rule on the…

Jeff Davis Examines Potential Legal Challenges to New 340B Medicare Payment Rule

Medicare will cut billions from 340B, expand site-neutral payments in 2027

Regulators finalized a rule Wednesday that would slash payments for drugs in the controversial 340B program and equalize some payments between care sites. Hospitals railed against the rule.

Also covered by BioPharma Dive, Healthcare Dive

Medicare Plans Rarely Cover Anti-Obesity Drugs for Other FDA-Approved Purposes

Expanding uses for GLP-1s have not translated into broader coverage, new research shows.

CY 2027 OPPS Final Rule: What the 340B Changes Mean for Hospitals, Patients, and Pharma

Digital Health’s GLP-1 Strategy: “You Didn’t Come for the Drug. You Came for Health”

In a panel discussion, executives from Noom, Omada, Virta and Twin Health discussed how they are going beyond the pill in their GLP-1 strategy and responded to a question about whether they will exist two-to-three years from now.

EBSA Releases Final Rule on PBM Fee Disclosure

EBSA Releases Final Rule on PBM Fee Disclosure spassin@amcp.org Fri, 11/06/2026 - 13:05 On November 2, 2026, the Employee Benefits Security Administration (EBSA) within the Department of Labor (DOL) published a final rule titled Improving Transparency into…

Also covered by Business Group on Health

CMS seeks input on Medicare Part D pharmacy contract standards

2027 Medicare OPPS final rule cuts 340B payments, expands site-neutral rates

In the 2027 Medicare final rule for hospital outpatient departments, CMS slightly mitigated several issues that providers had cited regarding the proposed version of the rule. Those steps have not assuaged stakeholder concerns about the rule’s impact on…

Labor Department finalizes sweeping PBM disclosure rule

Starting in 2027, the controversial drug middlemen will have to share a broad swath of fee and compensation data with self-funded employer clients. Employers cheered the rule, while PBMs slammed it as government overreach.

Also covered by Healthcare Dive, Healthcare Finance

CMS Finalizes 2027 OPPS Rule

CMS finalizes rule to codify Medicare Drug Price Negotiation Program

Medicare Outpatient Final Rule Expands Surgical Options, Lowers Out-of-Pocket Costs for 340B Drugs - Centers for Medicare & Medicaid Services | CMS (.gov)